Terumo Aktie
| 18,30EUR | 0,20EUR | 1,10% |
WKN: 867003 / ISIN: JP3546800008
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 83,87 |
| Nomura Asset Management Co., Ltd. | 8,22 |
| Dai-ichi Life Holdings, Inc. | 4,05 |
| Meiji Yasuda Life Insurance Co. | 3,28 |
| Asset Management One Co., Ltd. | 2,89 |
| Daiwa Asset iFreeETF NIKKEI 225 (Yearly Dividend Type) (1320) | 2,15 |
| Terumo Lifescience Foundation | 1,97 |
| Mitsubishi UFJ Asset Management Co., Ltd. | 1,96 |
| National Mutual Insurance Fed. of Agricultural Cooperatives | 1,43 |
| Vanguard Total International Stock Index Fund | 1,34 |
| Mizuho Bank Pension Fund | 1,17 |
| Dai Nippon Printing Pension Fund | 1,04 |
| Terumo Corp. | 0,89 |
| Dai Ichi Life Insurance Pension Fund | 0,80 |
| Tokio Marine Holdings, Inc. | 0,74 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 26 438 | 26 482 | 28 294 | 30 207 | 30 591 |
| Umsatz pro Mitarbeiter in Mio. EUR | 23,79 | 23,18 | 24,86 | 27,15 | 30,14 |
Bilanz (in Mio. JPY) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 460 607 | 523 966 | 558 713 | 611 396 | 722 116 |
| Summe Anlagevermögen | 780 748 | 827 226 | 914 980 | 990 829 | 1 109 286 |
| Summe Aktiva | 1 241 355 | 1 351 192 | 1 473 693 | 1 602 225 | 1 831 402 |
Bilanz (in Mio. JPY) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 486 468 | 494 530 | 461 373 | 491 158 | 504 306 |
| Summe Eigenkapital | 754 882 | 856 662 | 1 012 313 | 1 111 063 | 1 327 090 |
| Summe Passiva | 1 241 350 | 1 351 192 | 1 473 686 | 1 602 221 | 1 831 396 |
Adresse
| 2-44-1 Hatagaya, 151-0072 Tokyo | |
| Telefon | +81 (3) 3374-8111 |
| Internet | https://www.terumo.co.jp |
Management
|
Hidenori Nishi
Independent Outside Director |
|
Hikaru Samejima
President & Chief Executive Officer |
|
James Rushworth
Chief Commercial Officer & Executive Officer |
|
Katsuya Takeuchi
Chief Information Officer & Executive Officer |
|
Kazuhisa Senshu
Chief Clinical & Regulatory Affairs Officer |
|
Keiya Ozawa
Outside Director |
|
Kosuke Matsumoto
Executive Officer & Manager-Sales Management |
|
Kyo Nishikawa
Director & Chief Human Resources Officer |
|
Masaichi Nakamura
Independent Outside Director |
|
Miho Mizuguchi
Chief Legal Officer & Compliance Manager |
|
Naoki Muto
Chief Financial & Accounting Officer |
|
Shinjiro Sato
Director |
|
Shouji Hatano
Director, Head-Compliance & Legal Affairs |
|
Soichiro Uno
Independent Outside Director |
|
Takanori Shibazaki
Director |
|
Toshiaki Takagi
Chairman |
|
Tsuyoshi Tomita
Senior Executive Officer & Manager-Medical Devices |
|
Yukiko Kuroda
Independent Outside Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
